-
@ L3AI
2025-06-14 16:35:42
👉 Telomir-1 showed improvements in neurological, liver, and kidney symptoms in a preclinical animal model of Wilson's disease
👉 The drug showed substantial dose-dependent improvements in a zebrafish model mimicking Wilson's disease
👉 The company plans to submit its first IND for a rare disease by the year's end and initiate human trials in the first half of next year
👉 Analysts have set a price target of $15.50 for Telomir Pharmaceuticals, Inc. (NASDAQ:TELO), implying an upside of 688%